The agreement comes ahead of the China launch of a beverage containing BerriQi — a boysenberry-based ingredient aimed at preventing inflammation-mediated changes in lung tissue.
BNZL was formed in 1989 and is a grower-owned co-operative that promotes and manages the growing of boysenberries.
This agreement has been in the works for 12 months, and follows research from Anagenix and Plant & Food Research, a New Zealand Crown Research Institute, on boysenberries and lung health.
Last year we reported how a study from the organisation claimed that regular boysenberry consumption may improve lung function by reducing symptoms associated with inflammation of the airways.
Anagenix MD Chris Johnson said: “Toxic particles we inhale every day can cause the walls of the air sacs (alveoli) in your lungs to become thick, stiff and scarred from inflammation. BerriQi
“Pollution is a widespread problem and Boysenberry is a small crop by comparison. This exclusive supply arrangement with BNZL will ensure sustainability and supply of BerriQi to countries that are facing the daily onslaught of pollution, such as China.”